Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2022 09:00 ET | Source: Nexien BioPharma, Inc.

Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor

DENVER, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Nexien BioPharma Inc. (OTCQB: NXEN) ("Nexien" or the "Company") today announced that it has retained Dr. Benedikt Schoser as an advisor to the Company. Dr....